Коронарное кровообращение и возобновление клиники ишемической болезни сердца после интракоронарного стентирования
Аннотация
Об авторе
Г. А. БерезовскаяРоссия
Список литературы
1. Li Y., Yang D., Lu L. et al. Thermodilutional Confirmation of Coronary Microvascular Dysfunction in Patients With Recurrent Angina After Successful Percutaneous Coronary Intervention // Can J Cardiol. 2015. Vol. 31. № 8. P. 989-97. doi: 10.1016/j.cjca.2015.03.004.
2. Byrne R.A., Joner M., Alfonso F. et al. Treatment of instent restenosis. In: Bhatt D.L., (ed.) // Interventional Cardiology: A Companion to Braunwald‘s Heart Disease. Elsevier; 2015. Print ISBN9780323262194. Electronic ISBN9780323264556.
3. Hofma S.H., van der Giessen W.J., van Dalen B.M. et al. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation // Eur Heart J. 2006. Vol. 27. № 2. Р. 166-170.
4. Pendyala L.K., Yin X., Li J. et al. The first-generation drug-eluting stents and coronary endothelial dysfunction // JACC Cardiovasc Interv. 2009. Vol. 2. № 12. Р. 1169-1177.
5. DeBord L. Manual for stress echocardiography / L. DeBord. - Burlingame, CA, LWDC&E, 1993. - 206 p.
6. Hemker H.C., Giesen P., Al Dieri R. et al. Calibrated automated thrombin generation measurement in clotting plasma // Pathophysiol Haemost Thromb. 2003. Vol. 33. P. 4-15.
7. Dargaud Y., Trzeciak M.C., Bordet J.C. et al. Use of calibrated automated thrombinography +/- thrombomodulin to recognize the prothrombotic phenotype // Thromb. Haemost. 2006. Vol. 96. № 5. P. 562-567.
8. Byrne R.A., Joner M., Kastrati A. Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Gruntzig Lecture ESC 2014. // Eur Heart J. 2015. Vol. 36. № 47. P. 3320-3331. doi: 10.1093/eurheartj/ehv511.
9. Vassalli G., Klersy C., De Servi S. et al. Can the optimal type of stent be predicted based on clinical risk factors? A subgroup analysis of the randomized BASKET-PROVE trial. BASKET-PROVE Investigators // Am Heart J. 2016. Vol. 173. P. 1-7. doi: 10.1016/j.ahj.2015.11.007.
10. Siller-Matula J.M., Schwameis M., Blann A. et al. Thrombin as a multi-functional enzyme. Focus on in vitro and in vivo effects // Thromb Haemost. 2011. Vol. 106. №.60. P. 1020-33. doi: 10.1160/TH10-11-0711.
11. Bouwens E.A., Stavenuiter F., Mosnier L.O. Mechanisms of anticoagulant and cytoprotective actions of the protein C pathway // J Thromb Haemost. 2013. Vol. 11. Suppl 1. P. 242-253.
Рецензия
Для цитирования:
Березовская Г.А. Коронарное кровообращение и возобновление клиники ишемической болезни сердца после интракоронарного стентирования. Регионарное кровообращение и микроциркуляция. 2016;15(3):57-63. https://doi.org/10.24884/1682-6655-2016-15-3-57-63
For citation:
Berezovskaya G.A. Coronary circulation and renewal of heart coronary disease clinic after intracoronary stenting. Regional blood circulation and microcirculation. 2016;15(3):57-63. (In Russ.) https://doi.org/10.24884/1682-6655-2016-15-3-57-63